Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Chen

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Proteome Research|November 30, 2021
Comparative Proteomic Analysis of HPV(+) Oropharyngeal Squamous Cell Carcinoma RecurrenceAllen S Ho, Aaron Robinson, Wonwoo Shon, et al.
Thyroid : Official Journal of the American Thyroid Association|September 2, 2021
Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer VariantsAllen S Ho, Michael Luu, Iram Shafqat, et al.
Head & Neck|June 22, 2023
Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging systemAllen S Ho, Michael Luu, Bonnie L Balzer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2022
Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931Diana J Lu, Michael Luu, Christopher Gay, et al.
Oral Oncology|June 23, 2024
Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinomaAmanda J Bastien, Jewel Ng, Iris Cong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2016
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ AgonistsXiaodong Li, Shanaka Stanislaus, Frank Asuncion, et al.
JAMA Oncology|September 15, 2022
Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled TrialAllen S Ho, Sungjin Kim, Cynthia Zalt, et al.
Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Journal of Medicinal Chemistry|May 15, 2010
Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)Murielle M Véniant, Clarence Hale, Randall W Hungate, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Proteome Research|November 30, 2021
Comparative Proteomic Analysis of HPV(+) Oropharyngeal Squamous Cell Carcinoma RecurrenceAllen S Ho, Aaron Robinson, Wonwoo Shon, et al.
Thyroid : Official Journal of the American Thyroid Association|September 2, 2021
Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer VariantsAllen S Ho, Michael Luu, Iram Shafqat, et al.
Head & Neck|June 22, 2023
Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging systemAllen S Ho, Michael Luu, Bonnie L Balzer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2022
Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931Diana J Lu, Michael Luu, Christopher Gay, et al.
Oral Oncology|June 23, 2024
Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinomaAmanda J Bastien, Jewel Ng, Iris Cong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2016
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ AgonistsXiaodong Li, Shanaka Stanislaus, Frank Asuncion, et al.
JAMA Oncology|September 15, 2022
Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled TrialAllen S Ho, Sungjin Kim, Cynthia Zalt, et al.
Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Journal of Medicinal Chemistry|May 15, 2010
Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)Murielle M Véniant, Clarence Hale, Randall W Hungate, et al.
Pageof 9